Literature DB >> 7696859

Synthesis of neoglycopeptides and analyses of their biodistribution in vivo to identify tissue specific uptake and novel putative membrane lectins.

D Gupta1, A Surolia.   

Abstract

Complex type N-linked oligosaccharides derived from fetuin, fibrinogen and thyroglobulin were coupled to acetyltyrosine affording a series of neoglycopeptides with retention of terminal structures and the beta-anomeric configuration of their reducing end N-acetylglycosamine residue. The neoglycopeptides thus synthesized could be labelled to high specific activities with 125I in the aromatic side chain of tyrosine. Analysis of the fate of these neoglycopeptides in conjunction with inhibition with asialofetuin and oligosaccharides of defined structure in mice in vivo revealed the uptake of galactosylated biantennary compound by kidneys, in addition to the known itinerary of triantennary galactosylated complex oligosaccharide from fetuin to liver and the galactosylated biantennary chain with fucosylation in the core to bone marrows. On the other hand, the agalacto, aglucosamino biantennary chains with and without fucosylation in the core region are taken up by submaxillary glands while the conserved trimannosyl core with fucose is primarily concentrated in stomach tissue. These studies thus define new routes for the uptake of complex N-linked glycans and also subserve to identify lectins presumably involved in their recognition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696859     DOI: 10.1007/bf00731307

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  43 in total

1.  In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration.

Authors:  I R McDougall; J K Dunnick; M L Goris; J P Kriss
Journal:  J Nucl Med       Date:  1975-06       Impact factor: 10.057

2.  Asparagine-linked sugar chains of fetuin: occurrence of tetrasialyl triantennary sugar chains containing the Gal beta 1----3GlcNAc sequence.

Authors:  S Takasaki; A Kobata
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

Review 3.  Lectins as cell recognition molecules.

Authors:  N Sharon; H Lis
Journal:  Science       Date:  1989-10-13       Impact factor: 47.728

4.  Hepatic uptake of proteins coupled to fetuin glycopeptide.

Authors:  J C Rogers; S Kornfeld
Journal:  Biochem Biophys Res Commun       Date:  1971-11-05       Impact factor: 3.575

5.  Isolation of glycopeptides containing O-linked oligosaccharides by lectin affinity chromatography on jacalin-agarose.

Authors:  G L Hortin
Journal:  Anal Biochem       Date:  1990-12       Impact factor: 3.365

6.  Comparison of N-glycosides of fetuins from different species and human alpha 2-HS-glycoprotein.

Authors:  T Hayase; K G Rice; K M Dziegielewska; M Kuhlenschmidt; T Reilly; Y C Lee
Journal:  Biochemistry       Date:  1992-05-26       Impact factor: 3.162

Review 7.  Glycobiology: a growing field for drug design.

Authors:  K A Karlsson
Journal:  Trends Pharmacol Sci       Date:  1991-07       Impact factor: 14.819

8.  1-N-glycyl beta-oligosaccharide derivatives as stable intermediates for the formation of glycoconjugate probes.

Authors:  I D Manger; T W Rademacher; R A Dwek
Journal:  Biochemistry       Date:  1992-11-10       Impact factor: 3.162

9.  Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides.

Authors:  R R Townsend; E Hilliker; Y T Li; R A Laine; W R Bell; Y C Lee
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Structure of carbohydrate unit A or porcine thyroglobulin.

Authors:  T Tsuji; K Yamamoto; T Irimura; T Osawa
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

View more
  1 in total

1.  Tyramine-containing poly(4-nitrophenylacrylate) as iodinatable ligand carrier in biodistribution analysis.

Authors:  S Kojima; S André; E Y Korchagina; N V Bovin; H J Gabius
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.